#35 Acute Coronary Syndrome and TIMI Risk Sco...

MASLD affects nearly one in three adults worldwide, yet many patients remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? When is a FIB-4 enough, and when should we move to elastography or hepatology referr ...  Show more

What blood pressure should we target in patients on hemodialysis? Why volume control remains the foundation of treatment? How blood pressure targets differ from the general population. Learn practical pearls on medication timing around dialysis, drug dialyzability, antihypertensi ...  Show more

This is a topic podcast on myocardial infarction (MI) and Acute Coronary Syndrome (ACS). There is a lot more to managing ACS then just recgonizing who has tombstone ST elevations on their EKG and activating the cath lab. In this episode, we'll go through the entire ACS spectrum f ...  Show more

In this episode I cover acute coronary syndrome.

If you want to follow along with written notes on acute coronary syndrome go to https://zerotofinals.com/medicine/cardiology/acs/ or find the cardiology se ...

So this time we're going to be looking at the HUGE topic of acute coronary syndrome (ACS)! ACS ranges from patients who appear well at the time of their presentation, to those that have arrhythmias, haemodynamic instability, to those that are in cardiac arrest!

There ar ...

Acute Coronary Syndromes (ACS) Special Guest: Nick Servati, PharmD, BCCP 04:55 – Pathophysiology/Clinical presentation 12:40 – “MONA” myths 20:05 – P2Y12 pretreatment 24:25 – Thrombolytics in ACS 30:35 – Anticoagulation 38:55 – Vasopressors/Inotropes 49:50 – IV antiplatelet agent ...  Show more